The <i>TREM2</i> H157Y Variant Influences Microglial Phagocytosis, Polarization, and Inflammatory Cytokine Release
Previously, we reported that H157Y, a rare coding variant on exon 3 of the triggering receptor expressed on myeloid cells 2 gene (<i>TREM2</i>), was associated with Alzheimer’s disease (AD) risk in a Han Chinese population. To date, how this variant increases AD risk has remained unclear...
Main Authors: | Xin-Xin Fu, Shuai-Yu Chen, Hui-Wen Lian, Yang Deng, Rui Duan, Ying-Dong Zhang, Teng Jiang |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-04-01
|
Series: | Brain Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-3425/13/4/642 |
Similar Items
-
Trem2 H157Y increases soluble TREM2 production and reduces amyloid pathology
by: Wenhui Qiao, et al.
Published: (2023-01-01) -
Interrogation of human microglial phagocytosis by CRISPR genome editing
by: Jason Cheng-Yu Chang, et al.
Published: (2023-07-01) -
Amyloid-beta modulates microglial responses by binding to the triggering receptor expressed on myeloid cells 2 (TREM2)
by: Li Zhong, et al.
Published: (2018-03-01) -
Enhancing protective microglial activities with a dual function TREM2 antibody to the stalk region
by: Kai Schlepckow, et al.
Published: (2020-04-01) -
TREM2 in Alzheimer’s Disease: Microglial Survival and Energy Metabolism
by: Honghua Zheng, et al.
Published: (2018-11-01)